Net loss of Orchid Pharma reported to Rs 12.61 crore in the quarter ended December 2025 as against net profit of Rs 20.78 crore during the previous quarter ended December 2024. Sales declined 4.63% to Rs 207.27 crore in the quarter ended December 2025 as against Rs 217.34 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales207.27217.34 -5 OPM %0.7512.13 - PBDT3.9931.06 -87 PBT-5.0422.45 PL NP-12.6120.78 PL Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net loss of Orchid Pharma reported to Rs 5.72 crore in the quarter ended September 2025 as against net profit of Rs 27.24 crore during the previous quarter ended September 2024. Sales declined 13.10% to Rs 193.52 crore in the quarter ended September 2025 as against Rs 222.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales193.52222.70 -13 OPM %-0.7613.62 - PBDT5.5734.53 -84 PBT-3.3325.90 PL NP-5.7227.24 PL Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Orchid Pharma announced that the Annual General Meeting(AGM) of the company will be held on 20 September 2025.Powered by Capital Market - Live News